 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Treatment Action Group |
| Street 1: | 261 5th Ave, Suite 2110 |
| Street 2: | |
| City: | New York |
| Province: | NY |
| Post Code: | 10016 |
| Country: | United States of America |
| Phone: | 2122537922 |
| Organization Email: | tag@treatmentactiongroup.org |
| Web Site: | http://www.treatmentactiongroup.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developed Country NGO |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Community-Based Organization (CBO) |
| Organization Description: | |
| TAG is a community-based HIV/AIDS research and treatment advocacy organization with focus areas in basic science, immunology, antiretroviral drug development, community education and mobilization, and TB/HIV. | |
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy |
Other Organization Information | |
| Total number of staff in your organization: | 6 - 10 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Other partners |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Through supporting the CDC's TB Research Trial Consortium, participating in national policy development through the Advisory Council on the Elimination of TB, and increasing support for TB programs and research within the US national budget. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
United States of America |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Drug-Resistant TB: Monitoring the development and scale-up of diagnostics and treatment for drug-resistant TB and assessing the contributions of key stakeholders including, national leadership, the Global Laboratory Initiative, and the Global Drug Facility towards the scale up of DR-TB treatment. TB-HIV: Advocacy for the scale-up for of TB/HIV collaborative services. TAG participates on the TB/HIV Working Group and works to ensure that new tools being developed are effective in addressing TB in people with HIV. New Diagnostics: Monitoring the pipeline of new TB diagnostics and advocating for increased research and a comprehensive TB diagnostics portfolio. Tracking resources available for R&D for TB diagnostics and comparing them against the targets set by the Global Plan to Stop TB 2011-2015. New TB Drugs: Monitoring the pipeline of new TB drugs and advocating for increased research and a comprehensive TB drugs portfolio. Tracking resources available for R&D for TB drugs compared to the targets set by the Global Plan to Stop TB 2011-2015. TAG participates in the Stakeholders Association of the New TB Drugs Working Group. New TB Vaccines: Monitoring the pipeline of new TB vaccines and advocating for increased research and a comprehensive TB vaccines portfolio. Tracking resources available for R&D for TB vaccines compared to the targets set by the Global Plan to Stop TB 2011-2015. Fundamental Research: Monitoring fundamental TB research and advocating for increased research, increased research funding, and a comprehensive TB fundamental research portfolio. Tracking resources available for TB fundamental research compared to the targets set by the Global Plan to Stop TB 2011-2015. Research: Monitoring TB operational research and advocating for increased research to improve programmatic implementation. Tracking resources available for TB operational research compared to the targets set by the Global Plan to Stop TB 2011-2015. |
|
Declaration | |
| Declaration of interests: N/A. | |
| Application date: | |
| Last updated: | August 17, 2015 |